EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Neuropathology in an α-synuclein preformed fibril mouse model occurs independent of the Parkinson's disease-linked lysosomal ATP13A2 protein

Caio M Massari, Dylan J Dues, Alexis Bergsma, Kayla Sipple, Maxwell Frye, Erin T Williams, Darren J Moore

Neurobiology of Disease · 2024

DOI: 10.1016/j.nbd.2024.106701 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurobiology of Disease, 2024. Verfasst von Caio M Massari und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI 49503, USA. Hauptthemen laut MEDLINE: alpha-Synuclein, Proton-Translocating ATPases, Disease Models, Animal, Mice, Knockout. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Loss-of-function mutations in the ATP13A2 (PARK9) gene are implicated in early-onset autosomal recessive Parkinson's disease (PD) and other neurodegenerative disorders. ATP13A2 encodes a lysosomal transmembrane P5B-type ATPase that is highly expressed in brain and specifically within the substantia nigra pars compacta (SNc). Recent studies have revealed its normal role as a lysosomal polyamine transporter, although its contribution to PD-related pathology remains unclear. Cellular studies report that ATP13A2 can regulate α-synuclein (α-syn) secretion via exosomes. However, the relationship between ATP13A2 and α-syn in animal models remains inconclusive. ATP13A2 knockout (KO) mice exhibit lysosomal abnormalities and reactive astrogliosis but do not develop PD-related neuropathology. Studies manipulating α-syn levels in mice lacking ATP13A2 indicate minimal effects on pathology. The delivery of α-syn preformed fibrils (PFFs) into the mouse striatum is a well-defined model to study the development and spread of α-syn pathology. In this study we unilaterally injected wild-type (WT) and homozygous ATP13A2 KO mice with mouse α-syn PFFs in the striatum and evaluated mice for neuropathology after 6 months. The distribution, spread and extent of α-syn aggregation in multiple regions of the mouse brain was largely independent of ATP13A2 expression. The loss of nigrostriatal pathway dopaminergic neurons and their nerve terminals induced by PFFs were equivalent in WT and ATP13A2 KO mice. Reactive astrogliosis was induced equivalently by α-syn PFFs in WT and KO mice but was already significantly higher in ATP13A2 KO mice due to pre-existing reactive gliosis. We did not identify asymmetric motor disturbances, microglial activation, or axonal damage induced by α-syn PFFs in WT or KO mice. Although α-syn PFFs induce an increase in lysosomal number in the SNc in general, TH-positive dopaminergic neurons did not exhibit either increased lysosomal area or intensity, regardless of genotype. Our study evaluating the spread of α-syn pathology reveals no exacerbation of α-syn pathology, neuronal loss, astrogliosis or motor deficits in ATP13A2 KO mice, suggesting that selective lysosomal abnormalities resulting from ATP13A2 loss do not play a major role in α-syn clearance or propagation in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinProton-Translocating ATPasesDisease Models, AnimalMice, KnockoutParkinson DiseaseAnimalsMiceLysosomesMice, Inbred C57BLMaleDopaminergic Neurons

Stichwörter der Autor:innen

ATP13A2Alpha-synucleinLysosomeNeurodegenerationParkinson's disease

Substanzen

alpha-SynucleinProton-Translocating ATPasesATP13A2 protein, mouse

Autor:innen und Institutionen

  • Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI 49503, USA.
  • West Michigan Neurodegenerative Diseases (MiND) Program, Van Andel Institute, Grand Rapids, MI 49503, USA.
  • Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI 49503, USA. Electronic address: darren.moore@vai.org.

Zitieren

APA

Massari, C. M., Dues, D. J., Bergsma, A., Sipple, K., Frye, M., Williams, E. T., & Moore, D. J. (2024). Neuropathology in an α-synuclein preformed fibril mouse model occurs independent of the Parkinson's disease-linked lysosomal ATP13A2 protein. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2024.106701

Vancouver

Massari CM, Dues DJ, Bergsma A, Sipple K, Frye M, Williams ET, et al. Neuropathology in an α-synuclein preformed fibril mouse model occurs independent of the Parkinson's disease-linked lysosomal ATP13A2 protein. Neurobiology of Disease. 2024. doi:10.1016/j.nbd.2024.106701

BibTeX
@article{Massari2024,
  author = {Massari, Caio M and Dues, Dylan J and Bergsma, Alexis and Sipple, Kayla and Frye, Maxwell and Williams, Erin T and Moore, Darren J},
  title = {Neuropathology in an α-synuclein preformed fibril mouse model occurs independent of the Parkinson's disease-linked lysosomal ATP13A2 protein},
  journal = {Neurobiology of Disease},
  year = {2024},
  doi = {10.1016/j.nbd.2024.106701}
}
Kostenlos starten →